Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05580419

Impact of 4PCP on Practitioner and Patient Outcomes

Impact of a Novel Community-Based Biobehavioral Chronic Pain Team Training Program (4PCP) on Practitioner and Patient Outcomes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,188 (estimated)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
14 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Reducing opioid prescribing and improving outcomes in patients with chronic pain would benefit our nation. Neither addiction nor chronic pain spares any race, gender, or particular socio-economic status. This study is investigating a potentially inexpensive way of providing a previously costly service (the intensive chronic pain rehabilitation program), which is why insurers stopped covering it. Although it is unusual for an application from an academic institution to include a startup company (PainSTakers, LLC) as the curriculum provider, this is actually a long-term strength of this program, and the reason NIH recommended this route. It ensures that 4PCP will ultimately sustain itself rather than require government support for its continuation. Support for this application is not to provide the curriculum, but to determine if it is effective in the outcomes expected to be found. The curriculum is being provided freely only as an incentive for practitioners to participate in the research portion of the study. If the study is able to demonstrate its clinical effectiveness, the next step will be to show a positive economic impact for health care institutions and for health insurers who may then wish to support the program for their practitioners and their patients.

Detailed description

Practitioner procedures: After the completion of informed consent, practitioners will be sent their first set of surveys (Baseline). 1 week before the first day of the practitioner's course, they will be sent a second set of surveys (Time 0). 6 months after course completion, practitioners will be sent their next set of surveys (Follow Up 1). 6 months after the distribution of Follow Up Survey 1, practitioners will be sent their next set of surveys (Follow Up 2). 6 months after the distribution of Follow Up Survey 2, practitioners will be sent their next set of surveys (Follow Up 3). 6 months after the distribution of Follow Up Survey 3, practitioners will be sent their final set of surveys (Follow Up 4). Patient procedures: After the completion of informed consent, patients will be sent their first set of surveys (Baseline). 1 week before the first day of the patient's practitioner's course, they will be sent a second set of surveys (Time 0). 6 months after their practitioner's course completion, patients will be sent their next set of surveys (Follow Up 1). 6 months after the distribution of Follow Up Survey 1, patients will be sent their next set of surveys (Follow Up 2). 6 months after the distribution of Follow Up Survey 2, patients will be sent their next set of surveys (Follow Up 3). 6 months after the distribution of Follow Up Survey 3, patients will be sent their final set of surveys (Follow Up 4). Practitioner measures: * Demographics * HC-PAIRS * Mini Z \& Burnout * PABS-PT * Skills Comparison * Multi-Disc Perspective Questionnaire * CPPP (for MDs/DOs) * Know Pain-12 Patient measures: * Demographics * Medication information * PEG-3 * PCS * PROMIS 8A * PROMIS Global Health * PROMIS Pain Interference * GAD-7 * PHQ-8 * Secondary measures abstracted from state prescribing records Practitioner interventions: 4PCP training course Patient interventions: No direct interventions, but concepts practitioners learn from the 4PCP curriculum may change the way the practitioner continues care with the patient.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL4PCP Course4PCP is a training framework for the management of chronic pain and gives practitioners lasting knowledge on how to better care for chronic pain patients.

Timeline

Start date
2023-03-17
Primary completion
2027-09-01
Completion
2027-09-01
First posted
2022-10-14
Last updated
2025-11-25

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05580419. Inclusion in this directory is not an endorsement.